This article was originally published in The Gray Sheet
Launches Clearfix meniscal screw for use in repairing traumatic tears within the meniscus of the knee through a minimally invasive arthroscopic approach, the firm announces Oct. 13. Cleared via 510(k) in February, the bioabsorbable device will be released abroad in stages throughout late 1998 as various in-country approvals are granted. The patented screw works by compressing the meniscal tear during surgery and biodegrades into the tissue after the site heals
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.